Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00282724 | Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis | PHASE2 | COMPLETED | 98 | — | — | Jan 1, 2006 | Apr 1, 2007 | Sep 26, 2011 | 16 | Belgium, Canada +7 |
| Name | Type | Description |
|---|---|---|
| Liarozole | DRUG | - |
Inclusion Criteria: * Subjects of either sex aged 14 years or older. * Clinical diagnosis of lamellar ichthyosis * Women of childbearing potential should use appropriate contraception * Women of childbearing potential should have a negative pregnancy test at screening visit. * Subjects are, except ...